NewsRx

Search our medical news database

Drug Law Weekly

Susan Hasty, Publisher

Table of Contents . . . October 4th, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Drug Law Weekly | Other Publications

Collaborations - Aetna announces alliance with Standard Life for prescription drug plans

Generex Biotechnology Corp. - Buccal drug delivery company receives Australian patent

Healthcare Costs - Humana announces preferred pharmacy network

Inst. of Criminalistics & Criminology, Brussels - Researchers' findings advance diagnostics research

Lil' Drug Store Products, Inc. - Retailers scramble to provide safe, legal cold remedies

Medicare - Review of Medicare drug plans shows consumer choice lowers costs

Mergers & Acquisitions - Acquisition of PacifiCare positions UnitedHealth for Medicare growth

Mutual of Omaha - Insurance provider teams with Coventry to offer Medicare Part D plans

National Research Council of Canada - Microbes and products have potential in management of allergic asthma

ReGen Therapeutics Plc - Therapeutics company enters option agreement for zolpidem's new uses

Research Australia - BRAVE program provides help for children with anxiety

SkyePharma - Bronchodilator inhalation powder for asthma, COPD launched in Germany

Society of Gynecologic Oncologists - Gynecological oncology organization president testifies in support of H.R. 1245

Tobacco Use - Caron Foundation supports New Jersey's ban on smoking in dorms

Torchmark Corp. - United American gets Medicare Part D prescription drug plans approval from CMS

Academy Medical Center, Amsterdam - Triple-modality approach used to treat patients with cervical carcinoma

Ajou University, Suwon - Atherosclerotic patients should be divided for prognostic, therapeutic purposes

Alliance Pharmaceutical - Oxygent maker transfers assets of its subsidiary to MultiCell Technologies

Alnylam Pharmaceuticals - Pharma companies partner to discover therapeutics based on RNA interference

American Medical Association - High-dose radiation reduces risk of prostate cancer recurrence

Amgen - U.S. FDA expands Neulasta label

Amicus Therapeutics - Pharmacological chaperone developer raises $55M in financing

Amicus Therapeutics - Results study of Amigal for Fabry disease announced, phase II commences

Angiotech Pharmaceuticals - European approval granted for drug-eluting stent system

Antisoma - AS1404 lung cancer study reaches recruitment target

Berlex Biosciences - Findings in virology provide new insights

BioCryst Pharmaceuticals, Inc. - Phase II trial initiated for Fodosine in chronic lymphocytic leukemia

BioElectronics Corp. - Canadian health authorities clear pain patch for marketing

BioFocus - Deal signed for medicinal chemistry services

BioTime, Inc. - Aqueous-based synthetic solutions maker plans rights offering

Biomedical Primate Research Center, Rijswijk - Alternate priming approaches enhance hepatitis C vaccine in rhesus macaques

Blue Heron Biotechnology, Inc. - Gene synthesis company gets U.S. NIH grant for propagating difficult genes

Boston Scientific Corp. - Drug-eluting stent trials recognized as meeting ESC treatment guidelines

Bristol-Myers Squibb Company - U.S. FDA panel recommends approval of rheumatoid arthritis drug

British Medical Journal - Potential new treatment approach for severe asthma uncovered

British Nutrition Foundation - Integrated approach to tackling metabolic syndrome presented

CDC Foundation - Kaiser Permanente contributes $2 million for public health response to Katrina

CHU, Nantes - Administration of mylotarg yielded high rate of complete hematologic remission

Cardiology - Excluding deprivation from heart disease risk is jeopardizing thousands of lives

Celera Diagnostics - Diagnostics company extends collaboration with Merck in Alzheimer research

Center for Medical Parasitology, Copenhagen - Roles of Plasmodium mutations in chloroquine therapy examined

Chiba Cancer Center - Vinorelbine and gemcitabine used as third-line chemotherapy for refractory NSCLC

Chiba University - Reports describe recent advances in transplant medicine research

China Agriculture University - Procedure for large-scale preparation of plasmid DNA developed

Chinese Academy of Medical Sciences, Beijing - Muramyl dipeptide C augments hepatitis B therapy

Chinese Academy of Sciences, Shanghai -  Andrographis paniculata component enhances leukocyte chemotaxis

Columbia University, New York - Method may provide effective, alternative treatment for coronary artery disease

Cornell University - Recent findings in hepatitis b therapy provide new insights

Cornell University, New York City - Celastrol has promise as a neuroprotective agent for treatment of PD, HD

Corvinus University of Budapest - Microbiological safety of two chilled meals improved by gamma irradiation

Cutting Edge Information - Makers of cancer therapies spend $85 million on marketing

DOR BioPharma Inc. - New data illuminates research in anthrax vaccines

Deutsche Forschungsgemeinschaft - DFG to fund nine clinical trials

Diabetes Complications - ACTOS reduces rate of heart attacks, strokes and death in type 2 diabetes

Elhuyar Fundazioa - Team aims to develop, evaluate antibacterial steel surfaces

Endovasc - Liprostin parent appoints new CFO

Erasme University Hospital - Immunostimulatory properties of dendritic cells examined

Fisher Biosciences - Biosciences company adds Cellomics technologies for cellular screening

Forbes Medi-Tech - IND application submitted for cholesterol-lowering drug, FM-VP4

Fourth Military Medical University - Studies advance knowledge in melanoma vaccines research

Fred Hutchinson Cancer Research Center, Seattle - Stem cell transplant survivors are as healthy as non-transplant patients

Gentium - Defibrotide maker to commence phase III trial following discussions with FDA

GlaxoSmithKline - GlaxoSmithKline announces U.S. FDA approval of Fluarix

Hospital JM Morales Meseguer, Murcia - Pneumonia severity associated with Legionella urinary antigen test

Impax Laboratories - Final U.S. FDA approval granted for generic version of Glucophage XR

MGI Pharma - U.S. FDA approvable letter issued for Dacogen (decitabine) injection

March of Dimes Birth Defects Foundation - Birth defect organization restates position on folic acid consumption

Merck & Co. - U.S. FDA approves Proquad, a one-shot MMR and chickenpox vaccine

Sodexho USA - Food services company makes switch to trans fat free products

Technical Sourcing International - New medicine for angina has same ingredient as MSV 60

Tufts Center for the Study of Drug Development - Study shows faster FDA approval has not increased drugs withdrawn due to safety

U.S. Food & Drug Administration - LC/MS/MS method to analyze chloramphenicol in crab meat developed

Verispan - Contract awarded to provide data to U.S. Food and Drug Administration

etrials Worldwide, Inc. - Clinical software company CEO Cline named 'inspiring person in life sciences'

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook